Novel precision-based treatments for biliary tract cancer

晚期胆道癌的平均预期寿命约为12个月。该疾病在澳大利亚的发病率相对较低，因此需要以协作团队为基础的方法来推动进展。为了实现这一目标，我们在澳大利亚、泰国和日本建立了一个多学科研究团队。在这里，我们现在将在我们令人兴奋的初步发现的基础上，测试新的患者特异性治疗方法，并开发有效识别可能对免疫治疗有反应的患者的方法。

Advanced biliary tract cancer has a median life-expectancy of ~12 months. The relatively low incidence of the disease in Australia requires a collaborative team-based approach to drive progress. To achieve this, we have established a multidisciplinary research team based in Australia, Thailand and Japan. Here, we will now build on our exciting preliminary discoveries to test new patient-specific treatments, and develop methods to efficiently identify patients who may respond to immunotherapy.